Physician profile
Samuel P Walker
NPI 1639258254
$569.26
in general payments reported to CMS, 2019-2025
19 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.63 · 2020: $36.29 · 2021: $31.55 · 2022: $81.52 · 2023: $71.92 · 2024: $82.51 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $322.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $111.94 | 2022-2024 | Vraylar |
| Abbott Laboratories | $101.04 | 2025 | Ensite Precision |
| Pfizer INC. | $36.17 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $34.27 | 2025 | Eliquis |
| Medtronic, INC. | $31.59 | 2024 | Venaseal |
| Neurocrine Biosciences, INC. | $28.97 | 2024 | Ingrezza |
| Edwards Lifesciences Corporation | $26.75 | 2022 | |
| Sanofi-Aventis U.S. LLC | $26.57 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.44 | 2019-2020 | |
| Abiomed | $21.82 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.77 | 2019 | |
| Corcept Therapeutics | $16.66 | 2025 | Korlym |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.87 | 2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $13.70 | 2023 | |
| Smith+Nephew, INC. | $13.38 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.07 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.90 | 2021 | |
| Daiichi Sankyo INC. | $11.42 | 2019 | |
| Athena Bioscience, LLC | $9.93 | 2023 | Qdolo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.